Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer

Prognostic value of complete metabolic response on ¹⁸F-FDG-PET/CT after three cycles of neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer

OBJECTIVE: We investigated the prognostic value of complete metabolic response (CMR) on ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FDG-PET/CT) after 3 cycles of neoadjuvant chemotherapy (NAC) in advanced high-grade serous ovarian cancer (HGSC). METHODS: PET/CT at ba...

Full description

Bibliographic Details
Main Authors: Chung, Y.S (Author), Kang, W.J (Author), Kim, H.-S (Author), Kim, S. (Author), Kim, S.W (Author), Kim, Y. (Author), Lee, J.-Y (Author)
Format: Article
Language:English
Published: NLM (Medline) 2022
Subjects:
diagnostic imaging
female
Female
fluorodeoxyglucose f 18
Fluorodeoxyglucose F18
human
Humans
neoadjuvant therapy
Neoadjuvant Therapy
Ovarian Neoplasms
ovary tumor
Positron Emission Tomography Computed Tomography
positron emission tomography-computed tomography
procedures
prognosis
Prognosis
radiopharmaceutical agent
Radiopharmaceuticals
Retrospective Studies
retrospective study
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items